Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (27129)	6/21/2017 6:37:27 PM
From: Goose94	Read Replies (1) \| Respond to of 202365

MMJ-Cse new 52 week high, 7.5 cents

To: Goose94 who wrote (27129)	7/20/2017 12:44:02 PM
From: Goose94	Read Replies (2) \| Respond to of 202365

Matica Enterprises (MMJ-Cse) July 20, '17 is pleased to report that the Company has signed a letter of intent (“LOI”) for Matica to become a majority owner of a second late stage application under the Access To Cannabis for Medical Purposes Regulation (“ACMPR”) in Quebec. The target facility for this second ACMPR application is also a ten thousand square foot (10,000 sq. ft.) facility located in an industrial park in Saint-Laurent, Quebec in close proximity to our initial facility. The target is a late stage application with the goal of becoming a licensed producer under ACMPR and has completed the security clearance stage and is now in the review stage. Upon completion of due diligence, Matica will proceed to a definitive agreement (“Agreement”) which will allow Matica to acquire an initial sixty-five percent (65%) interest with the right to earn an additional five per cent (5%). Matica Enterprises CEO, Boris Ziger states, “This second Quebec facility establishes Matica as a serious player in the Quebec medical marijuana market.” After successful due diligence and signing of the definitive agreement, Matica is required to forward $75,000 in cash and issue 6,000,000 common shares of Matica. Matica will be required to provide funding of $2,200,000 to complete the build out of the medical marijuana facility in preparation for Health Canada inspection. This will earn Matica an initial sixty-five percent (65%) interest. After the completion of twelve (12) months of production at the facility, Matica will make a final payment of $675,000 and receive an additional five percent (5%) interest for a total seventy percent (70%) interest. For more information on Matica please visit the website at: www.maticaenterprises.com. On behalf of the Board of Directors MATICA ENTERPRISES INC. /s/Boris Ziger Boris Ziger, CEO & Chairman The Company’s filings are available for review at www.sedar.com and www.thecse.com. For further information, please contact Boris Ziger, Chief Executive Officer, at: Telephone: 416-304-9935 E-mail: info@maticaenterprises.com Website: www.maticaenterprises.com